Speaker Profile
BINH T. NGUYEN
Binh T. Nguyen, Pharm.D., M.S. Reg Sci, BCSCP, FHPE is an independent biopharmaceutical expert with over 22 years of experience in biopharmaceuticals (injectables, oral dosage, topical, liquid, transdermal, & inhalers), biologics/biosimilars, compounding pharmacies, positron emission tomography, dietary supplements, combination products, compliance, pre-approval, and application assessment while at the US FDA. He has extensive experience sterile compounding, airflow, insanitary conditions and sterility assurance, stability and beyond use dating (BUD), investigations and CAPAs, supplier and contract qualification and management, and media fills. Nguyen has served as a subject matter expert in drug regulation interpretation pertaining to and impact on drug quality, manufacturing, and control worldwide. He has expertise in training, mentoring, coaching, and auditing drug specialists internationally. He received the FDA Commissioner’s Special Citation and numerous other high-level FDA Recognition Awards. He’s developing an inspection software to conduct self-audit using FDA and other regulatory bodies’ regulations with artificial intelligence to empower auditors.
Binh T. Nguyen
November 15 2024
01 : 00 PM EST
75 Minutes
Quality Management Maturity (QMM) and Drug Supplies
Per 2024-01423.pdf (govinfo.gov), QMM refers to the extent to which drug manufacturing establishments implement quality management practices that prioritize patients, drive continual improvement, and enhance supply chain reliability through the strategic integration of business decisions and manufacturing operations with quality practices and technological advancements. As part of the QMM program initiative..